| A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria (NCT00002268) | Sandoz | |
| Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients (NCT00002234) | Gilead Sciences | |
| A Study of Nonoxynol-9 (N-9) and HIV Infection (NCT00000926) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients (NCT00002054) | Fisons | |
| A Study of the Effects of Advantage 24 on the Rectum (NCT00000929) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children (NCT00000837) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis (NCT00002077) | Pfizer | |
| A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP) (NCT00002434) | U.S. Bioscience | |
| A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS (NCT00002222) | Hoffmann-La Roche | |
| A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC (NCT00000680) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV (NCT00084058) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) (NCT00002156) | Ionis Pharmaceuticals, Inc. | |
| A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults (NCT00001031) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial (NCT00002267) | Pharmacia | |
| A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment (NCT00002334) | Hoffmann-La Roche | |
| Zidovudine and Lamivudine Given Once Versus Twice Daily (NCT00014014) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S) (NCT00000810) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML) (NCT00002395) | SmithKline Beecham | |
| Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC (NCT00001040) | Hoffmann-La Roche | |
| Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women (NCT00594373) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients (NCT00001116) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease (NCT00002033) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs (NCT00001103) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy (NCT00002073) | Ortho Pharmaceuticals | |
| Behavioral, Clinical and Basic Science Studies of Non-occupational Post-exposure Prophylaxis ("PEP-2") (NCT00473018) | University of California, San Francisco | |
| A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects (NCT00001053) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects (NCT00000795) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of 935U83 in HIV-Infected Patients (NCT00002338) | Glaxo Wellcome | |
| A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems (NCT00002315) | Glaxo Wellcome | |
| A Study of Nystatin in HIV-Infected Patients (NCT00002313) | Argus Pharmaceuticals | |
| A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus (NCT00000683) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Prospective Double-Blind Study of Retrovir in Early HIV Infection (NCT00002045) | Glaxo Wellcome | |
| SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy (NCT00000677) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III) (NCT00002048) | Glaxo Wellcome | |
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients (NCT00002408) | Shaman Pharmaceuticals | |
| A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients (NCT00002374) | Hoffmann-La Roche | |
| A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease (NCT00000880) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors (NCT00002361) | Merck Sharp & Dohme LLC | |
| A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible (NCT00000939) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002384) | Gilead Sciences | |
| A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection (NCT00000750) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients (NCT00000896) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children (NCT00000761) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Indinavir Taken With or Without DMP 266 (NCT00002393) | Dupont Merck | |
| Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine (NCT00000838) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of MKC-442 in HIV-Positive Patients (NCT00002413) | Triangle Pharmaceuticals | |
| Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00001013) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials (NCT00075062) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV (NCT00016783) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients (NCT00002445) | Cytran | |
| Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia (NCT00002414) | Centaur Pharmaceuticals | |
| A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients (NCT00000655) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 (NCT00002185) | Agouron Pharmaceuticals | |
| A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine (NCT00002096) | Hoffmann-La Roche | |
| A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes (NCT00001062) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492 (NCT00002265) | Hoffmann-La Roche | |
| The Effect of Teaching HIV-Infected Patients About HIV and Treatment (NCT00002409) | Glaxo Wellcome | |
| A Study of GENEVAX-HIV, a Possible Vaccine (NCT00002232) | Wyeth-Lederle Vaccines | |
| A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma (NCT00000769) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment (NCT00002144) | Astra USA | |
| A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy (NCT00000909) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants (NCT00000878) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia (NCT00000724) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible) (NCT00002079) | G D Searle | |
| A Study of Amprenavir in HIV-Infected Patients (NCT00002405) | Glaxo Wellcome | |
| Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents (NCT00091702) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection (NCT00000716) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss (NCT00001079) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo) (NCT00000777) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients (NCT00002438) | Janssen, LP | |
| A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 (NCT00002124) | Pharmacia and Upjohn | |
| A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS (NCT00002056) | LyphoMed | |
| A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT (NCT00000653) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002437) | Gilead Sciences | |
| A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs (NCT00002364) | Glaxo Wellcome | |
| A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs (NCT00002332) | Immunobiology Research Institute | |
| A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis (NCT00002016) | Sandoz | |
| Long-Term Effects of HIV Exposure and Infection in Children (NCT00006304) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients (NCT00000947) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328 (NCT00000943) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs (NCT00002217) | Glaxo Wellcome | |
| A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients (NCT00002150) | Hoechst Marion Roussel | |
| A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma (NCT00002318) | Sequus Pharmaceuticals | |
| Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns (NCT00000920) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection (NCT00002066) | Immunobiology Research Institute | |
| A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients (NCT00002401) | Pharmacia and Upjohn | |
| A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years (NCT00006509) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies (NCT00000714) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers (NCT00000879) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC) (NCT00000701) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 (NCT00000949) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00002443) | Merck Sharp & Dohme LLC | |
| A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia (NCT00000974) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure (NCT00000918) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease (NCT00002110) | Mylan Laboratories | |
| Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women (NCT00096694) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers (NCT00062530) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects (NCT00000792) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children (NCT00000811) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group (NCT00000815) | National Institute of Allergy and Infectious Diseases (NIAID) | |